“The agreement with Progressive Medical Inc. is a huge deal and a giant step in the right direction for LCMD and our LapCap2 product,” said Richard J. Prati, CEO of Life Care.
NEW SMYRNA BEACH, FL (PRWEB) May 13, 2016
Life Care Medical Devices Limited, (“Life Care,” “LCMD” or the “Company”) a medical device company focused on the development, production and distribution of non-invasive and minimally-invasive technologies, today announced that it has entered into a strategic distribution agreement for LapCap2® with Progressive Medical Inc., a leading distributor of specialty medical products throughout the country.
“The agreement with Progressive Medical Inc. is a huge deal and a giant step in the right direction for LCMD and our LapCap2 product,” said Richard J. Prati, Chief Executive Officer of Life Care. “Progressive Medical Inc. is among the top national distributors of medical devices in the United States with more than 75-plus sales reps across the country. Their team consists of seasoned veterans with tremendous expertise in laparoscopic devices and instruments. Progressive Medical Inc. is an optimal distribution partner for our company.”
“We are delighted to work with Life Care Medical Devices,” said Mark Martin, CEO of Progressive Medical Inc. “We are enthusiastic to be the sole distributor of LapCap2 in the United States and anticipate this becoming the standard for laparoscopic entry with Veress Needle.”
Today’s announcement with Progressive Medical Inc. comes just ahead of the renowned American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical and Scientific Meeting that begins tomorrow, May 14 and runs through May 17 in Washington, D.C.
“We are very excited to showcase LapCap2 at the ACOG annual meeting,” said Prati. “There’s no better venue to showcase the importance of our device to the laparoscopic surgical entry market.”
“LapCap2 acts as another pair of skilled hands, freeing the surgeon to concentrate fully on Veress needle entry,” said Camran R. Nezhat, M.D. FACOG, FACS, internationally distinguished minimally invasive and robotic surgeon and father of video-assisted endoscopic surgery. “There is a critical unmet need in laparoscopic surgery for consistent, reproducible entry and rapid creation of pneumoperitoneum. LapCap2 is specifically designed to address these needs. We believe LapCap2 will provide surgeons with additional confidence and advance the standard of care in laparoscopic surgery.”
LapCap2® is a proprietary device specifically designed to address a critical unmet need and advance the standard of care in laparoscopic surgery. It is a dome-shaped device that utilizes a negative pressure technique to raise the abdominal wall above critical organs and vessels during Veress needle entry. This new way of creating space in laparoscopic entry while stabilizing the abdomen conveys a number of benefits including: 1) Intuitively reduces the risk at the start of the procedure by increasing the size of the target zone; 2) Enables efficient laparoscopic entry; and 3) Less traumatic method of lifting the abdominal wall.
For LapCap2 sales inquiries and orders please contact Progressive Medical, Inc.
Anna Cunningham, Pharm.D
Clinical Affairs and Marketing Manager
Office: (314) 961-5786 X239
Fax: (314) 961-4535
Customer Service Manager
Office (314) 961-5786 X231
Fax: (314) 961-4535
Or Life Care Medical Devices Limited by email at CustomerService(at)lcmd(dot)com, by phone at USA/Canada 1-800-687-1389 or UK/Europe +44-(0)800-088-5368, or visit http://www.lcmd.com/products/lapcap2.
About Life Care Medical Devices Limited
Life Care Medical Devices Limited (LCMD), is a medical device company focused on the development, production and distribution of non-invasive and minimally-invasive technologies and products that reshape the treatment paradigm for medical procedures. The Company’s lead product, LapCap2® is an innovative, proprietary device specifically designed to advance standard of care for laparoscopic surgery by providing safe, rapid and repeatable access for minimally invasive abdominal procedures. Life Care is dedicated to improving surgery by working to ensure LapCap2 becomes the global standard for laparoscopic access. Life Care is also actively pursuing a robust growth strategy to expand its portfolio through the acquisition of synergistic products and technologies. For more information, please visit http://www.lcmd.com and connect with the Company on Twitter, Facebook and LinkedIn.
About Progressive Medical Inc.
Progressive Medical Inc. is a leading distributor of specialty medical products throughout the United States. PMI’s focus on innovative products helps clinicians to practice the highest quality care and increase safety, while also controlling overall costs in the areas of: surgery/anesthesia, interventional radiology, critical care and IV specialties.
PMI also understands the need for quick and reliable delivery of products, for clinically trained people who can answer questions and provide hands-on training, and for responsiveness to your overall business needs. Progressive Medical Inc. brings it all together: Innovative products for the practice of medicine, and an uncommon attention to your needs as a healthcare provider.
Forward Looking Statements
This press release may contain forward-looking statements regarding our prospective performance. Forward-looking statements are based on certain assumptions and describe future plans, strategies, and expectations of our company. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations include, without limitation: the ability to receive FDA and foreign regulatory approvals for our product candidates, including the LapCap2® Laparoscopic Access Device; the unpredictability of the size of the markets for, and market acceptance of, any of our products, including the LapCap2® Laparoscopic Access Device; our ability to produce and sell any approved products and the price we are able to realize for those products; our ability to enter into and maintain collaborations with third parties for the development and commercialization of our products, including the LapCap2® Laparoscopic Access Device; our need to obtain additional funding and our ability to obtain future funding on acceptable terms; our ability to retain and hire necessary employees and to staff our operations appropriately; and our dependence on the success of the LapCap2® Laparoscopic Access Device.